Category: Approval/Launch Region: Europe · United Kingdom Company: Ellipses Pharma Inc

Us Fda Approves Ellipses Pharma Ind Application For Ep0042 For Treatment Of Acute Myeloid Leukaemia

Us Fda Approves Ellipses Pharma Ind Application For Ep0042 For Treatment Of Acute Myeloid Leukaemia
Ellipses Pharma (Ellipses), A Global Drug Development Company Focused On Accelerating The Development Of Cancer Medicines And Treatments Through An Innovative Drug Development Model, Announced That The Us Food And Drug Administration (Fda) Has Cleared The Company

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!